After NVAX reported earnings last week it sold off in after hours, which left a big gap to fill upward from 202-226.
Vaccine stocks are ripping today, NVAX calls look good to fill the gap upward back to $226.
Once the gap is filled, if buyers are still in control then NVAX can test 227, 250.
Vaccine stocks are ripping today, NVAX calls look good to fill the gap upward back to $226.
Once the gap is filled, if buyers are still in control then NVAX can test 227, 250.
Note
GAP FILLED AND NVAX TESTED 260.. beautiful.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.